- Probability adjusted DCF for Life science companies involved in drug development is the industry standard
- Knowledge of probabilities of technical success in various therapeutic areas as well as our knowledge of international and domestic pharmaceuticals markets
- AID will develop an accurate valuation model for your or your potential partner's drug development portfolio
- Prepare you for your partnership (M&A, in-licensing, out-licensing, JVs, etc.) negotiations
- Understanding the value of the drug candidate(s) in your partner's portfolio in all possible target markets
- Valuation model from AID is a tool used throughout the negotiation process to ensure that you either bid/receive fair value for your partner's/your portfolio under any deal structure, whether in-licensing out-licensing, selling or acquiring
|
|